About this Event
We are attuned as never before to the need for ongoing biopharmaceutical innovation. Great opportunities exist to fund the next medical breakthrough but without a background in medicine how do you evaluate which ones have the best chance of success?
This course will help you develop an understanding of the major trends and factors affecting the sector, the complexities of bringing a drug to market, and how these factors can and should impact your investment decisions. This class introduces investors to the drug development process, the regulatory environment, and the latest trends in big pharma and biotech investing today.
You’ll learn:
About Your Presenter:
Dr. Maya Das is the ideal presenter for helping you navigate healthcare sector investing. With almost two decades in healthcare and life science Dr. Das works daily with drug, device, digital health and investment companies to consult, advise, evaluate assets, and reach key development milestones.
Dr. Das has served as the Vice President of Clinical Research at a clinical stage biopharmaceutical company. In addition she has led clinical development teams for autoimmune and rare disease programs in neurology, rheumatology, and nephrology. She has worked in clinical informatics and implementation, and managed health information technology programs for federal and state clients. During her time as Chief Resident she rotated at the National Cancer Institute (NCI) and the Food and Drug Administration (FDA). She is also registered to practice as an attorney before the U.S. Patent and Trademark Office (USPTO).
Note: if you are a current Golden Seeds member, you can take this course for free. Log in to your Golden Seeds member account on Dealum to register.
If you're not yet a member and join Golden Seeds within 3 months of taking this course, we'll apply the course fee to your membership!
Event Venue
Online
USD 250.00
